XXIX METAL CORP (XXIX.CA) Fundamental Analysis & Valuation

TSX-V:XXIX • CA9013201012

Current stock price

0.12 CAD
+0 (+4.35%)
Last:

This XXIX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. XXIX.CA Profitability Analysis

1.1 Basic Checks

  • XXIX had negative earnings in the past year.
  • XXIX had a negative operating cash flow in the past year.
  • In the past 5 years XXIX reported 4 times negative net income.
  • In the past 5 years XXIX always reported negative operating cash flow.
XXIX.CA Yearly Net Income VS EBIT VS OCF VS FCFXXIX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of XXIX (-38.90%) is worse than 60.02% of its industry peers.
  • XXIX has a Return On Equity of -72.13%. This is in the lower half of the industry: XXIX underperforms 62.76% of its industry peers.
Industry RankSector Rank
ROA -38.9%
ROE -72.13%
ROIC N/A
ROA(3y)-167.22%
ROA(5y)-108.68%
ROE(3y)-237.53%
ROE(5y)-150.86%
ROIC(3y)N/A
ROIC(5y)N/A
XXIX.CA Yearly ROA, ROE, ROICXXIX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • XXIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XXIX.CA Yearly Profit, Operating, Gross MarginsXXIX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

5

2. XXIX.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, XXIX has more shares outstanding
  • XXIX has more shares outstanding than it did 5 years ago.
  • XXIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
XXIX.CA Yearly Shares OutstandingXXIX.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
XXIX.CA Yearly Total Debt VS Total AssetsXXIX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • XXIX has an Altman-Z score of 0.39. This is a bad value and indicates that XXIX is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.39, XXIX is doing worse than 60.15% of the companies in the same industry.
  • XXIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACCN/A
WACCN/A
XXIX.CA Yearly LT Debt VS Equity VS FCFXXIX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

2.3 Liquidity

  • XXIX has a Current Ratio of 1.69. This is a normal value and indicates that XXIX is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of XXIX (1.69) is comparable to the rest of the industry.
  • A Quick Ratio of 1.69 indicates that XXIX should not have too much problems paying its short term obligations.
  • XXIX's Quick ratio of 1.69 is in line compared to the rest of the industry. XXIX outperforms 48.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
XXIX.CA Yearly Current Assets VS Current LiabilitesXXIX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

1

3. XXIX.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.86% over the past year.
EPS 1Y (TTM)84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, XXIX will show a very strong growth in Earnings Per Share. The EPS will grow by 30.93% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y71.43%
EPS Next 2Y30.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XXIX.CA Yearly EPS VS EstimatesXXIX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06

1

4. XXIX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XXIX. In the last year negative earnings were reported.
  • Also next year XXIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XXIX.CA Price Earnings VS Forward Price EarningsXXIX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XXIX.CA Per share dataXXIX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XXIX's earnings are expected to grow with 30.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.93%
EPS Next 3YN/A

0

5. XXIX.CA Dividend Analysis

5.1 Amount

  • XXIX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

XXIX.CA Fundamentals: All Metrics, Ratios and Statistics

XXIX METAL CORP

TSX-V:XXIX (4/30/2026, 7:00:00 PM)

0.12

+0 (+4.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry Strength92.13
Industry Growth19.4
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners1.84%
Ins Owner ChangeN/A
Market Cap45.91M
Revenue(TTM)N/A
Net Income(TTM)-3.76M
Analysts80
Price Target0.41 (241.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.8
P/tB 8.8
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -38.9%
ROE -72.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-167.22%
ROA(5y)-108.68%
ROE(3y)-237.53%
ROE(5y)-150.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 46.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 0.39
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.01%
EPS Next Y71.43%
EPS Next 2Y30.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.48%
OCF growth 3YN/A
OCF growth 5YN/A

XXIX METAL CORP / XXIX.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XXIX METAL CORP (XXIX.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to XXIX.CA.


Can you provide the valuation status for XXIX METAL CORP?

ChartMill assigns a valuation rating of 1 / 10 to XXIX METAL CORP (XXIX.CA). This can be considered as Overvalued.


What is the profitability of XXIX stock?

XXIX METAL CORP (XXIX.CA) has a profitability rating of 0 / 10.


What is the financial health of XXIX METAL CORP (XXIX.CA) stock?

The financial health rating of XXIX METAL CORP (XXIX.CA) is 5 / 10.